プラズモディアム・ファルシパラムのトランスポーター PfCRT の構造と耐薬性
Jonathan Kim1, Yong Zi Tan1,2, Kathryn J Wicht3
1Department of Physiology and Cellular Biophysics, Columbia University Irving Medical Center, New York, NY, USA.
Nature
|November 29, 2019
まとめ
プラズモディアム・ファルシパラムマラリアの薬剤耐性は大きな課題です この研究は,PfCRTトランスポーターの原子構造を明らかにし,主要な抗マラリア薬であるクロロキーンとピペラキーンに対する耐性をどのように変異させるかを説明します.
科学分野:
- 構造生物学
- 寄生虫学
- 薬物の発見
背景:
- 薬剤耐性プラズモディアム・ファルシパラムは マラリアの制御と撲滅の努力を阻害しています
- クロロキーン (CQ) とピペラキーン (PPQ) に対する耐性は,PfCRTトランスポーターの変異と関連しています.
- PfCRTのメカニズムを理解することは新しい抗マラリア薬の開発に不可欠です.
研究 の 目的:
- 薬剤耐性寄生虫からのPfCRTトランスポーターの原子構造を決定する.
- CQ と PPQ 耐性の基礎にある分子メカニズムを解明する.
- 抗マラリア薬の耐性についての洞察を将来的な治療開発に提供する.
主な方法:
- 単粒子の冷凍電子顕微鏡 (冷凍EM) で 3.2 Å の解像度.
- 構造的決定のための抗原結合断片 (Fab) 技術.
- インビトロ結合および輸送測定,機能研究,およびシリコ分析.
主要な成果:
- CQ耐性でPPQ敏感な寄生虫からのPfCRTイソフォームの構造を決定した.
- 主要な薬物相互作用部位である中央腔に定着する.
- PfCRTはCQを輸送するが,PPQを輸送しない.特定の変異によりPPQの輸送と抵抗が可能になる.
結論:
- 独特の構造的特徴とメカニズム的な違いは,CQとPPQに対する抵抗を媒介する.
- この研究は,抗マラリア薬の耐性メカニズムの 原子レベルでの洞察を提供します.
- この発見は 治療の失敗を理解し 次世代の抗マラリア薬の設計に 極めて重要です
さらに関連する動画
関連する概念動画
ABC Transporters: Exporter
6.2K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.2K
Carrier-Mediated Transport
941
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
941
Facilitated Diffusion
1.1K
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.1K
Cellular Membranes and Drug Transport
1.3K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.3K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
232
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
232
Hepatic Drug Clearance: Role of Transporters
272
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
272


